LGALS3

Galectin-3 · P17931 · LGALS3 on Sugi Atlas →

51,509 patent compounds predicted against LGALS3, 27,456 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL176296 SCHEMBL176296 1.00 20/20
SCHEMBL176329 SCHEMBL176329 0.76 20/20
SCHEMBL176281 SCHEMBL176281 0.76 20/20
SCHEMBL177372 SCHEMBL177372 0.74 20/20
SCHEMBL175953 SCHEMBL175953 0.71 19/20
Thiodigalactoside Thiodigalactoside (SCHEMBL116443) 1.00 11/20
SCHEMBL176226 SCHEMBL176226 0.49 9/20
SCHEMBL540778 SCHEMBL540778 0.66 8/20
SCHEMBL137947 SCHEMBL137947 0.58 8/20
SCHEMBL137948 SCHEMBL137948 0.58 8/20
SCHEMBL151041 SCHEMBL151041 0.58 8/20
SCHEMBL151685 SCHEMBL151685 0.58 8/20
SCHEMBL416020 SCHEMBL416020 0.58 8/20
SCHEMBL103814 SCHEMBL103814 0.56 8/20
SCHEMBL117333 SCHEMBL117333 0.66 7/20
SCHEMBL769001 SCHEMBL769001 0.65 7/20
SCHEMBL181379 SCHEMBL181379 0.63 7/20
SCHEMBL715283 SCHEMBL715283 0.61 7/20
SCHEMBL715284 SCHEMBL715284 0.61 7/20
SCHEMBL701054 SCHEMBL701054 0.40 7/20

Clinical trials — most relevant to LGALS3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF. PHASE3UNKNOWN
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes PHASE2UNKNOWN
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease PHASE2COMPLETED
Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction PHASE2UNKNOWN
Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA PHASE2COMPLETED
A Phase 2 Extension Study of Study GCS-100-CS-4002 PHASE2COMPLETED
TB006 for Autism Spectrum Disorder PHASE2RECRUITING
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors PHASE2COMPLETED
A Serum Galectin-3 Levels in Placenta Accreta Spectrum Pregnancies nanCOMPLETED
Galectin and Respiratory Weaning nanUNKNOWN
Galectin-3 Blockade in Patients With High Blood Pressure nanCOMPLETED
Effect of Low-Glycemic Index Mediterranean Diet on AGEs nanCOMPLETED
Galectin-3 for Thromboembolic Formation in Patients With Atrial Fibrillation CHA₂DS₂-VASc Scoring nanUNKNOWN
The Role of Galectins in the Non-invasive Diagnosis of Endometriosis nanUNKNOWN
Galectin-3 Binding Protein in Cardiovascular Disease and Chronic Heart Failure nanCOMPLETED
Galectin-3 as a Biomarker in Patients With Chagas Disease nanCOMPLETED
Testicular Proteins for Sperm Retrieval Prediction Protein1, Testis-Expressed Gene 101, and Lectin Galactoside-binding Protein in Predicting Surgical Sperm Retrieval in Men With Non-Obstructive Azoospermia nanUNKNOWN
Galectin-3 in Septic and Non-septic Acute Kidney Injury nanUNKNOWN
Urinary G3BP as a Novel Biomarker in Lupus Nephritis nanNOT_YET_RECRUITING
The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis Disease nanNOT_YET_RECRUITING
A Wearable Device and AI-Supported Diet and Exercise Intervention nanRECRUITING
Serum Galectin-3 as a Marker of Human Papillomavirus Infection nanCOMPLETED
Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter nanCOMPLETED
Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients nanUNKNOWN
Biomarkers for Risk Stratification After STEMI nanUNKNOWN
Galectin-3 in Patients With Endometriosis nanUNKNOWN
Measuring Immune Tolerance to Predict Miscarriage or Failed Embryo Transfer nanCOMPLETED
Novel Cardiovascular Biomarkers in Patients With Kidney Disease nanNOT_YET_RECRUITING
Correlational Study on the Biomarkers Application to the Prediction and Diagnosis of Cardiovascular Diseases nanCOMPLETED
Influence of Periodontitis and Coronary Heart Disease on Galectin-3 nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a LGALS3 binder may also engage these)

ProteinNameSimilarity
P47953 1.000 P47953 →
P47845 1.000 P47845 →
P16110 1.000 P16110 →
P08699 1.000 P08699 →
P38486 0.997 P38486 →
PEF1 Peflin 0.974 landscape →
Q641Z8 0.971 Q641Z8 →
P19198 0.971 P19198 →
Q8BFY6 0.970 Q8BFY6 →
ANXA7 Annexin A7 0.969 landscape →
Q5PQ53 0.969 Q5PQ53 →
Q2QY10 0.968 Q2QY10 →
LGALS4 Galectin-4 0.968 landscape →
Q8K419 0.968 Q8K419 →
Q4R5L5 0.968 Q4R5L5 →
Q29058 0.968 Q29058 →
O08573 0.968 O08573 →
Q8VDM6 0.967 Q8VDM6 →
P97840 0.967 P97840 →
P27214 0.966 P27214 →
Q5ZK05 0.966 Q5ZK05 →
HNRNPUL1 Heterogeneous nuclear ribonucleoprotein U-like protein 1 0.966 landscape →
Q2TA49 0.965 Q2TA49 →
Q92125 0.965 Q92125 →
P33477 0.965 P33477 →
ANXA11 Annexin A11 0.965 landscape →
P0CM58 0.965 P0CM58 →
Q4LBC8 0.965 Q4LBC8 →
Q8W4L0 0.965 Q8W4L0 →
P0CM59 0.964 P0CM59 →